Epigenetic manipulation may improve breast cancer treatment responses

Researchers explore the possibility of increasing TROP2 ADC activity by enhancing the expression of TROP2 on cancer cells.

Gene-editing field sees another merger, this time between Chroma Medicine and Nvelop Therapeutics

Two prominent gene-editing startups, Chroma Medicine and Nvelop Therapeutics, said Wednesday they will merge, forming a new company called nChroma Bio. The merger will combine

December 11, 2024

One year into 988 hotline, staff push for fixes to ambitious new system

One year after 988 launched as the new number for the national U.S. mental health hotline, the people behind the system say they’re still working

July 12, 2023

23andMe to lay off more than 200 employees amid business struggles

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: 23andMe said Monday it will

November 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.